Opérations
Qui sommes-nous ?
L’entreprise
Equipe
Nos bureaux
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Conseil en matière de dette
Equity Research
Levées de Fonds – Séries A, B, C ….
Stratégie et préparation de l’introduction en bourse
Industries
Services aux Entreprises
Consumer / Retail / E-commerce
Technologie industrielle
Life science et Santé
Software / TMT
Career
Evénements
Insights
News
Company News
Deal News
Carlsquare in the Media
Newsletter
Contactez-nous
Newsletter
FR
INT
DA
DE
SV
Main menu button
Equipe
Opérations
Contact
Equipe
Opérations
Contact
Actualités
Tout
Company News
Deal News
Equity Research
Events
Insights
Macro and markets
Media
Tout
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pila Pharma
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Tout
28 Août 2023
Initiation of coverage Nosa Plugs: Smelling success, plugging a hole in the market
Equity Research
Nosa Plugs
25 Août 2023
Equity Research Zazz Energy, Q2 2023: Intense quarter and restart expected soon
Equity Research
24 Août 2023
Equity research Observit, Q2 2023: Strong performance from software company
Equity Research
Observit
23 Août 2023
Equity Research Zazz Energy, Q2 2023: Intensive quarter awaiting the restart of the Amfilochia plant
Equity Research
23 Août 2023
Equity Research, Pharmiva: Merger with Peptonic could spark the fire
Equity Research
23 Août 2023
Carlsquare weekly market letter: China and the US are dithering. The boat is rocking
Equity Research
Carlsquare
22 Août 2023
Equity research Observit, Q2 2023: Strong performance from software company
Equity Research
Observit
22 Août 2023
Equity research update Kancera: Heart infarction results expected soon
Equity Research
Kancera
21 Août 2023
Research Update InCoax, Q2 2023: A potential new Tier 1 operating customer
Equity Research
InCoax
18 Août 2023
Research Update Ecoclime, Q2 2023: Sales growth much better than expected
Equity Research
18 Août 2023
First Impression InCoax, Q2 2023: Sales lower than expected, but good gross margin
Equity Research
InCoax
18 Août 2023
Equity research Risk Intelligence, Q2 2023: A strong quarter throughout
Equity Research
Risk Intelligence
17 Août 2023
First Impression Ecoclime, Q2 2023: 34% higher revenues than expected
Equity Research
16 Août 2023
Research Update Biosergen, Q2 2023: Stable in costs but delays in clinical timeline
Equity Research
Biosergen
16 Août 2023
Equity Research Risk Intelligence, Q2 2023: Better than expected revenues and profitability
Equity Research
Risk Intelligence
16 Août 2023
Carlsquare weekly market letter: The market breaks downwards
Equity Research
Carlsquare
14 Août 2023
Research Update H&D Wireless, Q2 2023: Good order intake, but not yet break-even
Equity Research
11 Août 2023
Video Interview H&D Wireless
Equity Research
11 Août 2023
First Impression H&D Wireless, Q2 2023: Improved order intake
Equity Research
09 Août 2023
Carlsquare weekly market letter: Oil and inflation stir emotions
Equity Research
Carlsquare
1
…
21
22
23
24
25
…
64